Starling, Amaal J.
Cady, Roger
Buse, Dawn C.
Buzby, Meghan
Spinale, Charlie
Steinberg, Kathy
Lenaburg, Kevin
Kymes, Steven
Funding for this research was provided by:
Lundbeck LLC, Deerfield, IL, USA
Article History
Received: 3 November 2023
Accepted: 22 January 2024
First Online: 26 February 2024
Declarations
:
: Not applicable.
: Not applicable.
: AJS has received consulting fees from AbbVie, Allergan, Amgen, Axsome Therapeutics, Everyday Health, Lundbeck, Med-IQ, Medscape, Neurolief, Satsuma, and WebMD. RC was an employee of Lundbeck LLC for the development and initiation of the survey and currently consults with Biohaven, Haleon, Lundbeck, and is a part time employee at Axon. DCB has received grant support from the US Food and Drug Administration, and the National Headache Foundation; served as a consultant and received honoraria from Allergan, Amgen/Novartis, Biohaven, Collegium, Eli Lilly, Lundbeck, and Teva; and served on the editorial board of <i>Current Pain and Headache Reports.</i> MB is an employee of the Coalition for Headache and Migraine Patients (CHAMP), an organization that receives sponsorship support from AbbVie, Amgen, Impel, Lilly, Lundbeck, and Teva. CS and KS are employees of The Harris Poll, a company that received funding from Lundbeck LLC for time spent conducting this research. KL has received consulting fees from AbbVie, Allergan, Impel, and Lundbeck; during the development and fielding of the survey. KL was an employee of the Coalition for Headache and Migraine Patients (CHAMP), an organization that receives sponsorship support from AbbVie, Amgen, Impel, Lilly, Lundbeck, and Teva. SK was an employee of Lundbeck LLC for the development and completion of the survey.